Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalie Khuseyinova

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Current Atherosclerosis Reports|August 12, 2006
Apolipoprotein A-I and risk for cardiovascular diseasesNatalie Khuseyinova, Wolfgang Koenig
Cardiovascular Drugs and Therapy|October 25, 2008
Lipoprotein-associated and secretory phospholipase A2 in cardiovascular disease: the epidemiological evidenceWolfgang Koenig, Natalie Khuseyinova
Arteriosclerosis, Thrombosis, and Vascular Biology|November 4, 2006
Biomarkers of atherosclerotic plaque instability and ruptureWolfgang Koenig, Natalie Khuseyinova
Molecular Diagnosis & Therapy|August 21, 2007
Predicting the risk of cardiovascular disease: where does lipoprotein-associated phospholipase A(2) fit in?Natalie Khuseyinova, Wolfgang Koenig
Current Opinion in Critical Care|September 1, 2006
Biomarkers of outcome from cardiovascular diseaseNatalie Khuseyinova, Wolfgang Koenig
Clinical Chemistry|December 25, 2007
Prospective study of high-sensitivity C-reactive protein as a determinant of mortality: results from the MONICA/KORA Augsburg Cohort Study, 1984-1998Wolfgang Koenig, Natalie Khuseyinova, Jens Baumert, et al.
Circulation|September 29, 2004
Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population: results from the 14-year follow-up of a large cohort from southern GermanyWolfgang Koenig, Natalie Khuseyinova, Hannelore Löwel, et al.
Atherosclerosis|December 13, 2006
Lipoprotein-associated phospholipase A2 concentrations in plasma are associated with the extent of coronary artery disease and correlate to adipose tissue levels of marine n-3 fatty acidsErik Berg Schmidt, Wolfgang Koenig, Natalie Khuseyinova, et al.
Circulation|July 27, 2005
Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general populationChrista Meisinger, Jens Baumert, Natalie Khuseyinova, et al.
Journal of the American College of Cardiology|October 3, 2006
Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: results from the 18-year follow-up of a large cohort from southern GermanyWolfgang Koenig, Natalie Khuseyinova, Jens Baumert, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Current Atherosclerosis Reports|August 12, 2006
Apolipoprotein A-I and risk for cardiovascular diseasesNatalie Khuseyinova, Wolfgang Koenig
Cardiovascular Drugs and Therapy|October 25, 2008
Lipoprotein-associated and secretory phospholipase A2 in cardiovascular disease: the epidemiological evidenceWolfgang Koenig, Natalie Khuseyinova
Arteriosclerosis, Thrombosis, and Vascular Biology|November 4, 2006
Biomarkers of atherosclerotic plaque instability and ruptureWolfgang Koenig, Natalie Khuseyinova
Molecular Diagnosis & Therapy|August 21, 2007
Predicting the risk of cardiovascular disease: where does lipoprotein-associated phospholipase A(2) fit in?Natalie Khuseyinova, Wolfgang Koenig
Current Opinion in Critical Care|September 1, 2006
Biomarkers of outcome from cardiovascular diseaseNatalie Khuseyinova, Wolfgang Koenig
Clinical Chemistry|December 25, 2007
Prospective study of high-sensitivity C-reactive protein as a determinant of mortality: results from the MONICA/KORA Augsburg Cohort Study, 1984-1998Wolfgang Koenig, Natalie Khuseyinova, Jens Baumert, et al.
Circulation|September 29, 2004
Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population: results from the 14-year follow-up of a large cohort from southern GermanyWolfgang Koenig, Natalie Khuseyinova, Hannelore Löwel, et al.
Atherosclerosis|December 13, 2006
Lipoprotein-associated phospholipase A2 concentrations in plasma are associated with the extent of coronary artery disease and correlate to adipose tissue levels of marine n-3 fatty acidsErik Berg Schmidt, Wolfgang Koenig, Natalie Khuseyinova, et al.
Circulation|July 27, 2005
Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general populationChrista Meisinger, Jens Baumert, Natalie Khuseyinova, et al.
Journal of the American College of Cardiology|October 3, 2006
Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: results from the 18-year follow-up of a large cohort from southern GermanyWolfgang Koenig, Natalie Khuseyinova, Jens Baumert, et al.
Pageof 3